TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/23 16:35 | 11/9/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Matrix Capital Management Company, LP | MA | T | P | 14,040 | 9.00 | 0 | 1,560 | 29 | 6,923 | I | |||||||||||||||
6/20/23 16:30 | 6/20/23 | ZNTL | Zentalis Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Matrix Capital Management Company, LP | MA | T | P | 107,862 | 22.66 | 0 | 4,760 | 52 | 13,960 | I | ||||||||||||||||
12/7/22 16:30 | 12/5/22 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Matrix Capital Management Company, LP | MA | T | P | 15,000 | 12.00 | 0 | 1,250 | 30 | 5,363 | I | |||||||||||||||
11/4/21 16:44 | 11/2/21 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Matrix Capital Management Company, LP | MA | T | P.d | 24,990 | 14.00 | 0 | 1,785 | 38 | 6,441 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |